Mahmood Ali, MD
Interventional Cardiology · Sunnyvale, TXNPI 1861432320
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,712 of the $8,597 with a category attached, or 78.1%. 21 manufacturers reported payments, led by Biotronik Inc. at 25.9% of the total. Reporting peaked in 2023 at $2,715 and has fallen 80.6% since, to $528 in 2025. That places this record below the midpoint for interventional cardiology clinicians in TX, where the typical reported total is $9,094.
Across 148 payments — averaging $58.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotronik Inc.$2K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$1K
- Philips North America LLC$1K
- Abbott$1K
- AstraZeneca$1K
- E.r. Squibb & Sons, L.L.C.$321
- plus $1K from 15 others
Across 7 payments — averaging $18,642 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$120K
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$11K
What the payments were for
- Travel & lodging$1,69920%
- Food & beverage$6,71278%
- Education$1862%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotronik Inc. | 27 | $2,228 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 27 | $1,382 |
| Philips North America LLC | 5 | $1,205 |
| Abbott | 32 | $1,043 |
| AstraZeneca | 15 | $1,037 |
| E.r. Squibb & Sons, L.L.C. | 8 | $321 |
| Boston Scientific | 11 | $279 |
| Veryan Medical Incorporated | 1 | $151 |
| Amgen | 2 | $147 |
| ZOLL Circulation Inc | 1 | $133 |
| Shockwave Medical, Inc | 1 | $128 |
| Medtronic | 4 | $127 |
| Teleflex LLC | 1 | $122 |
| Cagent Vascular Inc | 1 | $71 |
| Cardiovascular Systems Inc. | 4 | $70 |
| Cordis US CORP. | 2 | $37 |
| Kestra Medical Technology Services, Inc. | 1 | $35 |
| Abiomed | 1 | $29 |
| Gilead | 2 | $25 |
| Cathworks, Inc. | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IGT D Peripheral$1,047
- Acticor 7 VR-T DX$639
- Edora 8 DR-T$639
- Plexa ProMRI$639
- Sentus$639
- Solia$639
- FARXIGA$571
- LifeVest$350
- Confirm Rx$151
- BioMimics$151
- Assurity Pacemaker$140
- Temperature Management System$133
- Catheter$133
- Temperature Management System Start-Up Kit$133
- Vascular Lithotripsy$128
- TURNPIKE$122
- CAMZYOS$121
- Repatha$120
- Trilogy 100$106
How this compares
$8,597 in reported general payments places this provider in the 45th percentile of 686 interventional cardiology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $91,019 |
| Ranolazine ErRanolazine | 14 | $1,427 |
| ClopidogrelClopidogrel Bisulfate | 136 | $1,310 |
| Atorvastatin Calcium | 133 | $947 |
| Carvedilol | 168 | $898 |
| Metoprolol Succinate | 100 | $865 |
| Nitroglycerin | 29 | $853 |
| Potassium Chloride | 54 | $826 |
| Hydralazine Hcl | 60 | $803 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 62 | $712 |
| Furosemide | 128 | $549 |
| Digoxin | 25 | $534 |
| Nifedipine ErNifedipine | 31 | $494 |
| Amlodipine Besylate | 70 | $352 |
| Losartan Potassium | 38 | $302 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Sunnyvale
- Juan GranadaHouston$4.1M
- Vamsi KrishnaKyle$2M
- Jeffrey CarrTyler$1.9M
- John IsaacHouston$1.8M
- Robert ChiltonSan Antonio$1.3M
- Sameh SayfoPlano$1M
- Srinivasa PotluriPlano$781K
- Karim Al-AziziPlano$734K
- Robert StolerDallas$587K
- Peter MonteleoneKyle$461K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.